218 related articles for article (PubMed ID: 25098283)
1. Adverse events in cancer genetic testing: the third case series.
Bonadies DC; Brierley KL; Barnett RE; Baxter MD; Donenberg T; Ducaine WL; Ernst ME; Homer J; Judkins M; Lovick NM; Powers JM; Stanislaw C; Stark E; Stenner RC; Matloff ET
Cancer J; 2014; 20(4):246-53. PubMed ID: 25098283
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
3. Errors in delivery of cancer genetics services: implications for practice.
Brierley KL; Campfield D; Ducaine W; Dohany L; Donenberg T; Shannon K; Schwartz RC; Matloff ET
Conn Med; 2010 Aug; 74(7):413-23. PubMed ID: 20806621
[TBL] [Abstract][Full Text] [Related]
4. Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
Brierley KL; Blouch E; Cogswell W; Homer JP; Pencarinha D; Stanislaw CL; Matloff ET
Cancer J; 2012; 18(4):303-9. PubMed ID: 22846730
[TBL] [Abstract][Full Text] [Related]
5. Adverse Events in Genetic Testing: The Fourth Case Series.
Farmer MB; Bonadies DC; Mahon SM; Baker MJ; Ghate SM; Munro C; Nagaraj CB; Besser AG; Bui K; Csuy CM; Kirkpatrick B; McCarty AJ; McQuaid SW; Sebastian J; Sternen DL; Walsh LK; Matloff ET
Cancer J; 2019; 25(4):231-236. PubMed ID: 31335384
[TBL] [Abstract][Full Text] [Related]
6. Cost of genetic counseling and testing for BRCA1 and BRCA2 breast cancer susceptibility mutations.
Lawrence WF; Peshkin BN; Liang W; Isaacs C; Lerman C; Mandelblatt JS
Cancer Epidemiol Biomarkers Prev; 2001 May; 10(5):475-81. PubMed ID: 11352857
[TBL] [Abstract][Full Text] [Related]
7. What's New in Genetic Testing for Cancer Susceptibility?
Plichta JK; Griffin M; Thakuria J; Hughes KS
Oncology (Williston Park); 2016 Sep; 30(9):787-99. PubMed ID: 27633409
[TBL] [Abstract][Full Text] [Related]
8. Establishing a cancer risk evaluation program.
Calzone KA; Stopfer J; Blackwood A; Weber BL
Cancer Pract; 1997; 5(4):228-33. PubMed ID: 9250079
[TBL] [Abstract][Full Text] [Related]
9. Committee Opinion No. 693 Summary: Counseling About Genetic Testing and Communication of Genetic Test Results.
Obstet Gynecol; 2017 Apr; 129(4):771-772. PubMed ID: 28333813
[TBL] [Abstract][Full Text] [Related]
10. Cancer genetic counseling in public health care hospitals: the experience of three Brazilian services.
Palmero EI; Kalakun L; Schüler-Faccini L; Giugliani R; Regla Vargas F; Rocha JC; Ashton-Prolla P
Community Genet; 2007; 10(2):110-9. PubMed ID: 17380061
[TBL] [Abstract][Full Text] [Related]
11. Direct-to-patient BRCA1 testing: the Twoj Styl experience.
Gronwald J; Huzarski T; Byrski T; Debniak T; Metcalfe K; Narod SA; Lubiński J
Breast Cancer Res Treat; 2006 Dec; 100(3):239-45. PubMed ID: 16807675
[TBL] [Abstract][Full Text] [Related]
12. The nurse practitioner in family planning services: law and practice.
Roemer R
Fam Plann Popul Rep; 1977 Jun; 6(3):28-34. PubMed ID: 12259979
[TBL] [Abstract][Full Text] [Related]
13. Bioethical and clinical dilemmas of direct-to-consumer personal genomic testing: the problem of misattributed equivalence.
Eng C; Sharp RR
Sci Transl Med; 2010 Feb; 2(17):17cm5. PubMed ID: 20371476
[TBL] [Abstract][Full Text] [Related]
14. Genetic services in Portugal.
Santos H; Cordeiro I; Nunes L
Eur J Hum Genet; 1997; 5 Suppl 2():140-4. PubMed ID: 9450212
[No Abstract] [Full Text] [Related]
15. Challenges and Errors in Genetic Testing: The Fifth Case Series.
Farmer MB; Bonadies DC; Pederson HJ; Mraz KA; Whatley JW; Darnes DR; Denton JJ; De Rosa D; Heatherly A; Kenney J; Lane K; Paul D; Pelletier RC; Shannon K; Williams D; Matloff ET
Cancer J; 2021 Nov-Dec 01; 27(6):417-422. PubMed ID: 34904802
[TBL] [Abstract][Full Text] [Related]
16. Cancer genetics in primary care.
Culler D; Grimes SJ; Acheson LS; Wiesner GL
Prim Care; 2004 Sep; 31(3):649-83, xi. PubMed ID: 15331253
[TBL] [Abstract][Full Text] [Related]
17. A randomized trial of a breast/ovarian cancer genetic testing decision aid used as a communication aid during genetic counseling.
Wakefield CE; Meiser B; Homewood J; Taylor A; Gleeson M; Williams R; Tucker K;
Psychooncology; 2008 Aug; 17(8):844-54. PubMed ID: 18613319
[TBL] [Abstract][Full Text] [Related]
18. Practical aspects of delivering hereditary cancer risk counseling.
DeMarco TA; Smith KL; Nusbaum RH; Peshkin BN; Schwartz MD; Isaacs C
Semin Oncol; 2007 Oct; 34(5):369-78. PubMed ID: 17920890
[TBL] [Abstract][Full Text] [Related]
19. Committee Opinion No. 693: Counseling About Genetic Testing and Communication of Genetic Test Results.
Obstet Gynecol; 2017 Apr; 129(4):e96-e101. PubMed ID: 28333821
[TBL] [Abstract][Full Text] [Related]
20. Referral to cancer genetic counseling: are there stages of readiness?
O'Neill SM; Peters JA; Vogel VG; Feingold E; Rubinstein WS
Am J Med Genet C Semin Med Genet; 2006 Nov; 142C(4):221-31. PubMed ID: 17068804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
